DNA RNA and Cells

18 Oct 2007 Osiris Therapeutics Receives FDA Clearance to Initiate Phase III Pivotal Trial for Prochymal (TM) as a First Line Treatment for Acute Graft vs. Host Disease
12 Oct 2007 Hemispherx Biopharma Files New Drug Application for Ampligen(R)
09 Oct 2007 Isis Receives $1.25 Million Milestone Payment From iCo for Initiation of Phase 1 Study of iCo-007
09 Oct 2007 Isis Favorably Revises Financial Guidance and Introduces Mipomersen as Generic Name for ISIS 301012
06 Oct 2007 Isis Reports That ISIS 301012 is Well Tolerated in Patients Treated for Five Or More Months
06 Oct 2007 AVONTEC's drug candidate AVT-02 UE for the treatment of inflammatory skin diseases has entered a multiple dosing Phase I study
05 Oct 2007 Aastrom Announces Positive Interim Results From Phase I/II Study Involving Use of Vascular Repair Cells in Patients With Critical Limb Ischemia
05 Oct 2007 Isis Reports Positive Results of Phase 2 Study of ISIS 301012 in Heterozygous FH Patients
03 Oct 2007 Aegera Therapeutics Initiates Four Phase I/II Clinical Trials for AEG35156
02 Oct 2007 Transgene Extends Therapeutic Vaccine Candidate TG4040 Development Program Against Chronic Hepatitis C
25 Sep 2007 Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
21 Sep 2007 Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
21 Sep 2007 GenVec Technology Demonstrates Selective Anti-Cancer Activity
19 Sep 2007 Sangamo BioSciences Presents Data Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic
19 Sep 2007 VIRxSYS Presents Update on HIV Gene Therapy Clinical Trial at ICAAC
18 Sep 2007 Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis
14 Sep 2007 Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases
13 Sep 2007 ATL1102 Phase IIa Multiple Sclerosis Trial Update
06 Sep 2007 MediGene Completes Patient Recruitment for Clinical Trial of Cancer-Killing Virus NV1020
04 Sep 2007 Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
01 Sep 2007 ATL1103 for Growth & Sight Disorders Project Update
31 Aug 2007 Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
30 Aug 2007 Lorus advances clinical development of GTI-2040 combined with Ara-c in acute myeloid leukemia
30 Aug 2007 Phase II Study of IMC-A12 for Advanced Prostate Cancer Commences Patient Enrollment
29 Aug 2007 Journal of American College of Cardiology Publishes Positive Findings on Generx Now in Phase 3 for Heart Disease

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top